Related Experiment Video

Updated: Jul 15, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Does ofloxacin protect against BCG-related toxic effects in patients with bladder cancer?

Michael O'Donnell1

  • 1Department of Urology, University of Iowa, Iowa City, IA 52242-1089, USA. michael-odonnell@uiowa.edu

Nature Clinical Practice. Urology
|April 12, 2007
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Experiment Videos

Last Updated: Jul 15, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Bacillus Calmette-Guérin Therapy: Optimizing Outcomes amid Challenges.

The Urologic clinics of North America·2026

FLInt 2.0: robust and customizable single-shot integration in C. elegans.

G3 (Bethesda, Md.)·2026

FLInt 2.0: Robust and customizable single shot integration in C. elegans.

bioRxiv : the preprint server for biology·2026

Sticker shock: evaluation of a novel internal medicine clerkship high-value care curriculum using patient bills.

Academic medicine : journal of the Association of American Medical Colleges·2026

Exploring the link between unmet needs and quality of life in lymphoma survivors: a cross-sectional study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025

Effect of practice on the control of reach extent.

Experimental brain research·2025

The management of renal angiomyolipomas in a patient with tuberous sclerosis.

Nature clinical practice. Urology·2009

Inappropriate treatment of prostate cancer caused by heterophilic antibody interference.

Nature clinical practice. Urology·2009

Management of posterior urethral disruption injuries.

Nature clinical practice. Urology·2009

Utilization of lean management principles in the ambulatory clinic setting.

Nature clinical practice. Urology·2009

Bladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research direction.

Nature clinical practice. Urology·2009

Should patients undergoing surgery for renal cell carcinoma have a lymph node dissection?

Nature clinical practice. Urology·2009

Complete pathological response after neoadjuvant chemoimmunotherapy in PD-L1-negative unresectable primary hepatic small cell carcinoma: a case report and tumor microenvironment analysis.

Frontiers in immunology·2026

Keyhole Limpet Hemocyanin-Based Multimodal Management in Two Dogs with Presumptive Urothelial Carcinoma: Long-Term Clinical and Imaging Follow-Up.

Veterinary sciences·2026

Prenatal Chlorpyrifos Exposure Induces Ovarian Toxicity in Rat Offspring: Modulatory Potential of Curcumin.

Toxics·2026

From Follicle Development to Fertilization: How PCBs and PFAS May Shape Female Reproductive Health.

Toxics·2026

Enhancing Anti-Cancer Efficacy in Colorectal Cancer Through Cannabinoid and Sodium Pentaborate Co-Therapy.

Molecules (Basel, Switzerland)·2026

Anticancer Potential of Cherry Extracts and Major Flavonols: Focus on Quercetin and Kaempferol Molecular Mechanisms in Breast Cancer.

International journal of molecular sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us